Cargando…
TRimetazidine as an Agent to affeCt clopidogrEl Response: The TRACER Study
INTRODUCTION: This prospective study aimed to determine whether trimetazidine (TMZ) alters the pharmacodynamic (PD) effects of clopidogrel. METHODS: Patients with stable coronary artery disease (SCAD) (n = 24) who were actively treated with dual antiplatelet therapy (DAPT) of aspirin 81 mg daily and...
Autores principales: | Seecheran, Naveen, Seebalack, Victoria, Seecheran, Rajeev, Maharaj, Aarti, Boodhai, Brent, Seecheran, Valmiki, Persad, Sangeeta, Motilal, Shastri, Tello-Montoliu, Antonio, Schneider, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828882/ https://www.ncbi.nlm.nih.gov/pubmed/31292901 http://dx.doi.org/10.1007/s40119-019-0139-0 |
Ejemplares similares
-
Prevalence of clOpidogrel ‘resIstaNce’ in a selected population of patients undergoing elective percutaneous coronary intervention at a tertiary cardiovascular centre in Trinidad: the POINT pilot study
por: Seecheran, Naveen Anand, et al.
Publicado: (2019) -
The Effect of Low-Dose Ticagrelor on Platelet Function Profiles in Patients With Stable Coronary Artery Disease in Trinidad: The TWIST Pilot Study
por: Seecheran, Naveen, et al.
Publicado: (2020) -
Medical management of a suspected atrial myxoma in a nonagenarian
por: Kawall, Jessica, et al.
Publicado: (2020) -
Rivaroxaban as an Antithrombotic Agent in a Patient With ST-Segment Elevation Myocardial Infarction and Left Ventricular Thrombus: A Case Report
por: Seecheran, Rajeev, et al.
Publicado: (2017) -
Atypical presentation of critical left main disease in an HIV-infected patient
por: Seecheran, Rajeev, et al.
Publicado: (2018)